The Effect of Melatonin on TNBS-Induced Colitis
- 22 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 51 (9), 1538-1545
- https://doi.org/10.1007/s10620-005-9047-3
Abstract
Ulcerative colitis is a multifactorial inflammatory disease of the colon and rectum with an unknown etiology. The present study was undertaken to investigate the effect of melatonin administration on oxidative damage and apoptosis in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis. Rats were divided into four groups as follows: Group 1 (n=8)—TNBS colitis; Group 2 (n=8)—melatonin, 10 mg/kg/day ip, for 15 days in addition to TNBS; Group 3 (n=8)—melatonin alone, 10 mg/kg/day ip, for 15 days; and Group 4 (n=8)—isotonic saline solution, 1ml/rat ip, for 15 days (sham control group). Colonic myeloperoxidase (MPO) activities, malondialdehyde (MDA) levels, and glutathione (GSH) levels are indicators of oxidative damage, while caspase-3 activities reveal the degree of apoptosis of the colonic tissue. In all TNBS-treated rats, colonic MPO activity and MDA levels were found to be increased significantly compared to those in the sham group. Colonic MPO activity and MDA levels were significantly lower in the melatonin treatment group compared to TNBS-treated rats. GSH levels of colonic tissues were found to be significantly lower in TNBS-treated rats compared to the sham group. Treatment with melatonin significantly increased GSH levels compared to those in TNBS-treated rats. Caspas-3 activity of colonic tissues was found to be significantly higher in TNBS-treated rats compared to the sham group. Treatment with melatonin significantly decreased caspase-3 activity compared to that in TNBS-treated rats. These results imply a reduction in mucosal damage due to anti-inflammatory and anti-apoptotic effects of melatonin.Keywords
This publication has 37 references indexed in Scilit:
- The basic physiology and pathophysiology of melatoninSleep Medicine Reviews, 2005
- Protective effect of melatonin on contractile activity and oxidative injury induced by ischemia and reperfusion of rat ileumLife Sciences, 2005
- Apoptosis in tissue inflammation and allergic diseaseCurrent Opinion in Immunology, 2004
- New cytokine therapeutics for inflammatory bowel diseaseCytokine, 2004
- Protective role of melatonin given either before ischemia or prior to reperfusion on intestinal ischemia‐reperfusion damageJournal of Pineal Research, 2004
- Amelioration of methotrexate‐induced enteritis by melatonin in ratsCell Biochemistry and Function, 2004
- Suppression of Pro-Inflammatory Cytokine Release by Selective Inhibition of Inducible Nitric Oxide Synthase in Mucosal Explants from Patients with Ulcerative ColitisScandinavian Journal of Gastroenterology, 2003
- NF-κB/Rel/IκB: Implications in gastrointestinal diseasesGastroenterology, 2000
- Regulation and Significance of Apoptosis in the Stem Cells of the Gastrointestinal EpitheliumThe International Journal of Cell Cloning, 1997
- Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.Gut, 1996